Literature DB >> 2585439

Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma.

J J Baldwin1, G S Ponticello, P S Anderson, M E Christy, M A Murcko, W C Randall, H Schwam, M F Sugrue, J P Springer, P Gautheron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2585439     DOI： 10.1021/jm00132a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  21 in total

Review 1.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

Review 2.  Minireview: applied structural bioinformatics in proteomics.

Authors:  Yee Siew Choong; Gee Jun Tye; Theam Soon Lim
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

3.  Structural analysis of inhibitor binding to human carbonic anhydrase II.

Authors:  P A Boriack-Sjodin; S Zeitlin; H H Chen; L Crenshaw; S Gross; A Dantanarayana; P Delgado; J A May; T Dean; D W Christianson
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

4.  NMR structure-based drug design.

Authors:  S W Fesik
Journal:  J Biomol NMR       Date:  1993-05       Impact factor: 2.835

Review 5.  Carbonic anhydrases as disease markers.

Authors:  Sabina Zamanova; Ahmed M Shabana; Utpal K Mondal; Marc A Ilies
Journal:  Expert Opin Ther Pat       Date:  2019-06-17       Impact factor: 6.674

Review 6.  Cryo-EM in drug discovery: achievements, limitations and prospects.

Authors:  Jean-Paul Renaud; Ashwin Chari; Claudio Ciferri; Wen-Ti Liu; Hervé-William Rémigy; Holger Stark; Christian Wiesmann
Journal:  Nat Rev Drug Discov       Date:  2018-06-08       Impact factor: 84.694

7.  Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity.

Authors:  Kevin M Jude; Abir L Banerjee; Manas K Haldar; Sumathra Manokaran; Bidhan Roy; Sanku Mallik; D K Srivastava; David W Christianson
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

8.  BUILDER v.2: improving the chemistry of a de novo design strategy.

Authors:  D C Roe; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

Review 9.  Pharmacological advances in the treatment of glaucoma.

Authors:  J B Serle
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

10.  An ab initio study of di- and trifluorobenzene-benzene complexes as relevant to carbonic anhydrase II-drug interactions.

Authors:  Pooja P Chandra; Ahamindra Jain; Anne-Marie Sapse
Journal:  J Mol Model       Date:  2003-12-12       Impact factor: 1.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.